The Procter & Gamble Company (NYSE:PG) Stock Position Raised by Unigestion Holding SA

Unigestion Holding SA grew its stake in The Procter & Gamble Company (NYSE:PG - Free Report) by 22.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 272,441 shares of the company's stock after purchasing an additional 49,947 shares during the quarter. Procter & Gamble makes up approximately 2.3% of Unigestion Holding SA's investment portfolio, making the stock its 7th largest holding. Unigestion Holding SA's holdings in Procter & Gamble were worth $47,179,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Valued Wealth Advisors LLC grew its position in shares of Procter & Gamble by 51.5% during the 2nd quarter. Valued Wealth Advisors LLC now owns 544 shares of the company's stock valued at $90,000 after acquiring an additional 185 shares during the period. Phoenix Wealth Advisors lifted its position in shares of Procter & Gamble by 4.9% in the 2nd quarter. Phoenix Wealth Advisors now owns 6,954 shares of the company's stock worth $1,147,000 after purchasing an additional 326 shares during the period. James J. Burns & Company LLC lifted its position in Procter & Gamble by 76.6% during the second quarter. James J. Burns & Company LLC now owns 5,472 shares of the company's stock valued at $903,000 after buying an additional 2,373 shares during the period. Meadow Creek Wealth Advisors LLC increased its position in Procter & Gamble by 4.6% during the 2nd quarter. Meadow Creek Wealth Advisors LLC now owns 9,559 shares of the company's stock valued at $1,576,000 after buying an additional 419 shares in the last quarter. Finally, Patrick M Sweeney & Associates Inc. lifted its stake in shares of Procter & Gamble by 4.5% in the second quarter. Patrick M Sweeney & Associates Inc. now owns 5,502 shares of the company's stock worth $907,000 after buying an additional 236 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

Shares of PG stock traded down $1.59 on Wednesday, hitting $170.69. 5,236,628 shares of the company's stock were exchanged, compared to its average volume of 6,709,633. The stock has a market cap of $401.98 billion, a P/E ratio of 29.88, a price-to-earnings-growth ratio of 3.68 and a beta of 0.44. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $180.43. The company has a 50 day moving average of $170.70 and a 200 day moving average of $169.49.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the previous year, the business earned $1.83 EPS. The firm's revenue was down .6% compared to the same quarter last year. On average, equities research analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.36%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 69.48%.

Wall Street Analyst Weigh In

PG has been the topic of a number of analyst reports. Barclays cut shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 target price on the stock. in a research note on Monday, September 30th. DA Davidson upgraded Procter & Gamble from a "neutral" rating to a "buy" rating and raised their price target for the stock from $160.00 to $209.00 in a research report on Monday, November 25th. Hsbc Global Res upgraded Procter & Gamble to a "strong-buy" rating in a report on Friday, October 4th. Piper Sandler started coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a "neutral" rating and a $174.00 target price on the stock. Finally, JPMorgan Chase & Co. increased their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an "overweight" rating in a report on Thursday, September 19th. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble presently has an average rating of "Moderate Buy" and a consensus price target of $180.45.

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 12,800 shares of the company's stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares of the company's stock, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 83,080 shares of company stock worth $14,629,038. Insiders own 0.18% of the company's stock.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.